Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,904 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05008705Recruiting
Protein and muscle stimulation for hospitalized seniors
This trial tests whether increasing protein intake plus using a gentle electrical muscle stimulation device can help maintain or build muscle mass in older adults while they are hospitalized. It may help prevent muscle loss that can happen after short hospital stays.
São PauloAges 65 years+ - NCT07602933Recruiting
Light Therapy for Muscle Fatigue from Electrical Stimulation
This study tests whether light therapy can reduce muscle fatigue and damage caused by electrical muscle stimulation. Researchers want to see if this non-invasive light treatment helps muscles recover faster.
Porto Alegre, Rio Grande do SulAges 18–45 - NCT07599930Recruiting
Novel Snack for Perimenopausal Symptoms and Wellness
This study tests whether a specially designed snack can help reduce hot flashes, night sweats, mood changes, and other symptoms that happen during perimenopause (the years leading up to menopause). You'll eat the snack regularly and answer questions about how you feel.
London, LondonAges 40–55 - NCT07596966Recruiting
Propolis and Royal Jelly for High Blood Pressure
This study tests whether two bee products—propolis and royal jelly—can help reduce inflammation and stress in the body of people with high blood pressure. Researchers want to see if adding these supplements to your current blood pressure medication helps control the condition better.
Niterói, Rio de JaneiroAges 18–75 - NCT07600008RecruitingEarly Phase 1
Probiotics as a supplement for reflux disease management
This early-stage trial tests whether a probiotic supplement can help support treatment of reflux disease (GERD) in patients already taking a standard reflux medication. Researchers want to see if adding probiotics might improve symptoms or overall digestive health.
OlomoucAges 40–55 - NCT07598643RecruitingPhase 2
Study of tofacitinib for immune function in Down syndrome
This study tests if an oral medication called tofacitinib can help the immune system work better in children and young adults with Down syndrome, which may improve learning and development. The study will follow participants for 6 months.
Aurora, ColoradoAges 6–22 - NCT07595341Enrolling by invitation
Breathing Training for Competitive Swimmers
This study tests whether a special breathing-exercise program can improve how well swimmers' lungs work and their swimming performance. Researchers will teach swimmers techniques to strengthen the muscles used for breathing and measure how it affects their ability to swim.
MadridAges 18 years+ - NCT06629389RecruitingPhase 2
Cannabidiol (Kanbis) for Parkinson's symptoms
This trial tests whether cannabidiol (CBD) can help with Parkinson's disease symptoms. Researchers want to see if it's safe and effective for people with mild to moderate Parkinson's who are already on stable medications.
Mendoza, Mendoza ProvinceAges 40–80 - NCT05484128Recruiting
Probiotic for kids taking acid-reducing medicine
This trial studies whether a specific probiotic (Lactobacillus reuteri) is helpful for children who need acid-reducing medicine for reflux or stomach discomfort. It may help improve stomach symptoms while they are on or need treatment with proton pump inhibitors.
BariAges 1–14 - NCT05969275RecruitingPhase 2
Cell therapy trial for infection-related septic shock in ICU
This Phase 2 trial tests an immune-boosting cell therapy (umbilical mesenchymal stromal cells) in people with septic shock—when infection causes dangerous stress on the heart and other organs. The goal is to see if this treatment can improve outcomes compared with standard care.
Ottawa, OntarioAges 18 years+ - NCT06574503RecruitingPhase 3
New pill to prevent flu after exposure
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
HanzhouAges 12 years+ - NCT06717490Recruiting
Magnesium and blood clot prevention in laparoscopic gynecologic surgery
This study looks at whether giving magnesium sulfate during surgery can help prevent blood clots in women having laparoscopic gynecologic procedures. It may offer an extra layer of protection for those already receiving standard clot-preventing medication.
Athens, AtticaAges 18 years+ - NCT07589127Recruiting
Nerve Block for Pain Relief During Knee Replacement
This study tests whether blocking a specific nerve in the knee can reduce pain and improve recovery after total knee replacement surgery. You would receive this nerve block alongside standard anesthesia to see if it helps you need fewer pain medications afterward.
Hjelset, Møre og RomsdalAges 18–80 - NCT07592390RecruitingPhase 1/Phase 2
Cannabigerol Oil for Teens With ADHD
This study tests whether an oil made from cannabigerol (a compound from cannabis plants) can help teenagers with ADHD who haven't improved much with other treatments. The trial will check if it's safe and helps reduce ADHD symptoms.
Tubarão, Santa CatarinaAges 12–17 - NCT07589465Recruiting
Lactulose to Help Digestion Recover After Appendix Surgery
This study tests whether taking lactulose (a gentle laxative) after appendix removal helps your stomach and intestines work normally again. The trial compares lactulose to a placebo (inactive pill) to see which helps patients recover bowel function faster.
SichuanAges 18 years+ - NCT07590193RecruitingPhase 1
AMG 127 Safety Study in Healthy People and Type 2 Diabetes
This early-stage trial tests a new drug called AMG 127 to see if it's safe and how the body handles it. Researchers will enroll both healthy volunteers and people with type 2 diabetes to understand how the drug works in different groups.
Lake Forest, CaliforniaAges 18–75 - NCT07594093RecruitingPhase 1
A study of REGN20934 for adults with overweight or obesity
This trial tests a new medication, REGN20934, to see how safe it is and how it works in the body for adults who are overweight or have obesity. It may help if you are looking for new treatment options.
Glendale, CaliforniaAges 18–65 - NCT07589634RecruitingPhase 2
Tocilizumab to prevent side effects from ramantamig in multiple myeloma
This study tests whether a drug called tocilizumab can prevent serious side effects (cytokine release syndrome) when combined with a new cancer drug called ramantamig. You'll be eligible if you have multiple myeloma that has come back or stopped responding to prior treatments.
Goodyear, ArizonaAges 18 years+ - NCT07592689RecruitingPhase 3
DT120 Treatment for Major Depression
This study tests whether a new medication called DT120 can help people with moderate-to-severe depression feel better. You'd take the medication for several weeks while doctors track your mood and symptoms.
Little Rock, ArkansasAges 18–74 - NCT07594847RecruitingPhase 1
Safety study of HDM1002 tablets on heart rhythm in healthy adults
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
Zibo, ShangdongAges 18–45 - NCT07586930Recruiting
Testing a Supplement for Intestinal Health
This study tests whether a daily supplement can help improve gut health and reduce digestive symptoms like bloating, cramping, or irregular bowel habits. You'll undergo simple urine tests to measure how well your intestines are working.
Cork, IrelandAges 18–65 - NCT07591584Recruiting
Digestive Enzyme Blend for Bloating and Gas Relief
This study tests whether a daily digestive enzyme supplement designed to break down certain hard-to-digest foods can reduce bloating and belly pain. You'll use a smartphone app to track your symptoms over several weeks to see if the enzyme helps.
Los Angeles, CaliforniaAges 18 years+ - NCT07592585RecruitingPhase 3
Testing VC005 cream for mild-to-moderate eczema in teens and adults
This study tests a new medication called VC005 to treat atopic dermatitis (eczema)—a skin condition causing itching, redness, and inflammation. Researchers want to see if VC005 can safely reduce symptoms in people aged 12 and older with mild-to-moderate cases.
Nanjing, JiangsuAges 12 years+ - NCT07589595RecruitingPhase 2
Donanemab for Early Cognitive Decline with Lewy Bodies
This study tests donanemab, an investigational drug designed to target amyloid proteins in the brain that may contribute to cognitive decline in people with early dementia with Lewy bodies. The trial aims to see if this treatment can slow cognitive decline and help preserve thinking and memory.
Chandler, ArizonaAges 55–85
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,904 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.